SymbolODTX
NameODYSSEY THERAPEUTICS, INC.
SectorUNDEFINED
RegionUNDEFINED
IndustryBiological Products, (No Diagnostic Substances)
Address51 SLEEPER STREET, BOSTON, MA 02210
Telephone(212) 841-1000
Fax
Email
Website
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001882782
Description

None

2026-06-05 11:13

New Form SCHEDULE 13G - Odyssey Therapeutics, Inc. <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 0000315066-26-001419 <b>Size:</b> 11 KB

Read more
2026-05-18 21:20

New Form SCHEDULE 13G - Odyssey Therapeutics, Inc. <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0002044377-26-000002 <b>Size:</b> 15 KB

Read more
2026-05-18 19:30

New Form SCHEDULE 13D - Odyssey Therapeutics, Inc. <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001072613-26-000468 <b>Size:</b> 174 KB

Read more
2026-05-18 17:07

New Form SCHEDULE 13D - Odyssey Therapeutics, Inc. <b>Filed:</b> 2026-05-18 <b>AccNo:</b> 0001999371-26-011002 <b>Size:</b> 22 KB

Read more
2026-05-15 15:59

New Form SCHEDULE 13D - Odyssey Therapeutics, Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000950103-26-007273 <b>Size:</b> 25 KB

Read more
2026-05-13 21:10

TPG GP A, LLC 🟡 adjusted position in 1.4M shares (2 derivative) of Odyssey Therapeutics, Inc. (ODTX) at $18.00 ($25.0M) Transaction Date: May 11, 2026 | Filing ID: 010652

Read more
2026-05-12 21:37

Director Dimension Capital II, L.P. 🟡 adjusted position in 1.1M shares (1 derivative) of Odyssey Therapeutics, Inc. (ODTX) at $18.00 ($20.0M) Transaction Date: May 08, 2026 | Filing ID: 000417

Read more
2026-05-12 18:37

New Form 3 - Odyssey Therapeutics, Inc. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001012975-26-000416 <b>Size:</b> 6 KB

Read more
2026-05-12 01:11

SR ONE CAPITAL MANAGEMENT, LLC 🟡 adjusted position in 553.8K shares (15 derivative) of Odyssey Therapeutics, Inc. (ODTX) at $18.00 ($10.1M) Transaction Date: May 11, 2026 | Filing ID: 217656

Read more
2026-05-12 00:35

LEIDEN JEFFREY M 🟡 adjusted position in 631.2K shares (5 derivative) of Odyssey Therapeutics, Inc. (ODTX) at $20.00 ($11.4M) Transaction Date: May 07, 2026 | Filing ID: 217607

Read more